« Previous
Next »
American Heart Journal
Volume 150, Issue 4
, Pages 659-665
, October 2005
Electrocardiographic infarct size assessment after thrombolysis: Insights from the Acute Myocardial Infarction STudy ADenosine (AMISTAD) trial
References
- Myocardium at risk and infarct size after thrombolytic therapy for acute myocardial infarction: implications for the design of randomized trials of acute intervention. J Am Coll Cardiol. 1994;24:616
- . The role of sestamibi scintigraphy in the radio isotopic assessment of myocardial viability. J Nucl Med. 1992;33:1925–1930
- Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. N Engl J Med. 1993;328:685–691
- Beneficial effects of RheothRx injection in patients receiving thrombolytic therapy for acute myocardial infarction. Results of a randomized, double-blind, placebo-controlled trial. Circulation. 1996;94:298–307
- . Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction. Results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction Study of Adenosine (AMISTAD) trial. J Am Coll Cardiol. 1999;34:1711–1720
- Effect of intravenous streptokinase on the relation between initial ST-predicted size and final QRS-estimated size of acute myocardial infarcts. J Am Coll Cardiol. 1990;16:1252–1257
- Use of the 12-lead ECG to detect myocardial reperfusion and salvage during acute myocardial infarction. J Electrocardiol. 1992;25:281–286
- Importance of early and complete reperfusion to achieve myocardial salvage after thrombolysis in acute myocardial infarction. Am J Cardiol. 1992;70:1391–1396
- Development of ST-segment elevation and Q and R wave changes in acute myocardial infarction and the influence of thrombolytic therapy. Am J Cardiol. 1996;77:337–343
- Use of initial ST-segment deviation for prediction of final electrocardiographic size of acute myocardial infarct. Am J Cardiol. 1988;61:749–753
- Evaluation of formulas for estimating the final size of acute myocardial infarcts from quantitative ST-segment elevation on the initial standard 12-lead ECG. J Electrocardiol. 1991;24:77–83
- Evaluation of a QRS scoring system for estimating myocardial infarct size: V. Specificity and method of application of the complete system. Am J Cardiol. 1985;55:1485–1490
- Correlation of the complete version of the Selvester QRS scoring system with quantitative anatomic findings for multiple left ventricular myocardial infarcts. Am J Cardiol. 1992;69:465–469
- Value of electrocardiographic scoring systems for the assessment of thrombolytic therapy in acute myocardial infarction. The European Cooperative Study Group for Recombinant Tissue Type Plasminogen Activator. Eur Heart J. 1991;12:378–388
- Electrocardiographic measurement of infarct size after thrombolytic therapy. J Am Coll Cardiol. 1996;1:617–624
- Use of the QRS scoring system in the early estimation of myocardial infarct following reperfusion. J Electrocardiol. 1997;30:315–322
- Limitations of the electrocardiogram in estimating infarction size following acute reperfusion therapy. Ann Intern Med. 1991;114:264–270
- Estimates of myocardium at risk and collateral flow in acute myocardial infarction using electrocardiographic indexes with comparison to radionuclide and angiographic measures. J Am Coll Cardiol. 1995;26:338–393
- The Selvester 32-point QRS score for evaluation of myocardial infarct size after primary coronary angioplasty. Am J Cardiol. 1999;83:255–257
- Fluorine-18-deoxiglucose PET for assessment of viable myocardium in perfusion defects in 99m Tc Mibi SPECT: a comparative study in patients with coronary artery disease. Eur J Nucl Med. 1992;19:334–342
- Positron emission tomography detects evidence of viability in rest technetium-99m sestamibi defects. J Am Coll Cardiol. 1994;23:92–98
- . The initial electrocardiographic pattern in acute myocardial infarction: correlation with infarct size. J Electrocardiol. 1999;32(Suppl.):122–128
- . A regulatory authority's opinion about surrogate end points. In: Nimmo WS, Tucker GT editor. Clinical measurement in drug evaluation. New York: Wiley; 1985;
- Combined tissue type plasminogen activator and prostacyclin therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 4 Study Group. J Am Coll Cardiol. 1989;14:877–884
- Intravenous fluosol in the treatment of acute myocardial infarction. Results of the thrombolysis and angioplasty in myocardial infarction 9 trial. Circulation. 1994;90:114–120
- . ISIS: a randomized factorial trial assessing early oral captoprill, oral mononitrate and intravenous magnesium sulfate in 58,050 patients with suspected acute myocardial infarction. Lancet. 1995;345:669–685
- . Effects of RheothRx on mortality, morbidity, left ventricular function and infarct size in patients with acute myocardial infarction. Circulation. 1997;96:192–201
- . Free radicals, reperfusion and myocardial infarction therapy: European myocardial infarction project—free radicals pilot study. Eur Heart J (Suppl G). 1993;48–51
- Beneficial effects of RheothRx injection in patients receiving thrombolytic therapy for acute myocardial infarct results of a randomized double-blind, placebo-controlled trial. Circulation. 1996;94:298–307
PII: S0002-8703(04)00761-6
doi: 10.1016/j.ahj.2004.10.014
© 2005 Mosby, Inc. All rights reserved.
« Previous
Next »
American Heart Journal
Volume 150, Issue 4
, Pages 659-665
, October 2005
